Literature DB >> 27592685

Interplay between RNA-binding protein HuR and microRNA-125b regulates p53 mRNA translation in response to genotoxic stress.

Deepika Ahuja1, Ashish Goyal1, Partho Sarothi Ray1.   

Abstract

Tumor suppressor protein p53 plays a crucial role in maintaining genomic integrity in response to DNA damage. Regulation of translation of p53 mRNA is a major mode of regulation of p53 expression under genotoxic stress. The AU/U-rich element-binding protein HuR has been shown to bind to p53 mRNA 3'UTR and enhance translation in response to DNA-damaging UVC radiation. On the other hand, the microRNA miR-125b is reported to repress p53 expression and stress-induced apoptosis. Here, we show that UVC radiation causes an increase in miR-125b level in a biphasic manner, as well as nuclear cytoplasmic translocation of HuR. Binding of HuR to the p53 mRNA 3'UTR, especially at a site adjacent to the miR-125b target site, causes dissociation of the p53 mRNA from the RNA-induced silencing complex (RISC) and inhibits the miR-125b-mediated translation repression of p53. HuR prevents the oncogenic effect of miR-125b by reversing the decrease in apoptosis and increase in cell proliferation caused by the overexpression of miR-125b. The antagonistic interplay between miR-125b and HuR might play an important role in fine-tuning p53 gene expression at the post-transcriptional level, and thereby regulate the cellular response to genotoxic stress.

Entities:  

Keywords:  Cancer; DNA damage; HuR; RNA-binding protein; miR-125b; microRNA; p53; translation regulation

Mesh:

Substances:

Year:  2016        PMID: 27592685      PMCID: PMC5100343          DOI: 10.1080/15476286.2016.1229734

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  45 in total

1.  5'-3'-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage.

Authors:  Jing Chen; Michael B Kastan
Journal:  Genes Dev       Date:  2010-09-13       Impact factor: 11.361

2.  MicroRNA expression profiles in serous ovarian carcinoma.

Authors:  Eun Ji Nam; Heejei Yoon; Sang Wun Kim; Hoguen Kim; Young Tae Kim; Jae Hoon Kim; Jae Wook Kim; Sunghoon Kim
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

Review 3.  MicroRNA regulation by RNA-binding proteins and its implications for cancer.

Authors:  Marieke van Kouwenhove; Martijn Kedde; Reuven Agami
Journal:  Nat Rev Cancer       Date:  2011-08-05       Impact factor: 60.716

4.  Competitive regulation of nucleolin expression by HuR and miR-494.

Authors:  Kumiko Tominaga; Subramanya Srikantan; Eun Kyung Lee; Sarah S Subaran; Jennifer L Martindale; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2011-08-22       Impact factor: 4.272

5.  MicroRNA miR-125b causes leukemia.

Authors:  Marina Bousquet; Marian H Harris; Beiyan Zhou; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-30       Impact factor: 11.205

6.  MiR-125b protects against ethanol-induced apoptosis in neural crest cells and mouse embryos by targeting Bak 1 and PUMA.

Authors:  Xiaopan Chen; Jie Liu; Wen-ke Feng; Xiaoyang Wu; Shao-yu Chen
Journal:  Exp Neurol       Date:  2015-05-27       Impact factor: 5.330

7.  Translational regulation of human p53 gene expression.

Authors:  L Fu; M D Minden; S Benchimol
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

8.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

Authors:  Mark Bloomston; Wendy L Frankel; Fabio Petrocca; Stefano Volinia; Hansjuerg Alder; John P Hagan; Chang-Gong Liu; Darshna Bhatt; Cristian Taccioli; Carlo M Croce
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

9.  Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

Authors:  R Visone; P Pallante; A Vecchione; R Cirombella; M Ferracin; A Ferraro; S Volinia; S Coluzzi; V Leone; E Borbone; C-G Liu; F Petrocca; G Troncone; G A Calin; A Scarpa; C Colato; G Tallini; M Santoro; C M Croce; A Fusco
Journal:  Oncogene       Date:  2007-06-11       Impact factor: 9.867

10.  Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation.

Authors:  Marina Bousquet; Cathy Quelen; Roberto Rosati; Véronique Mansat-De Mas; Roberta La Starza; Christian Bastard; Eric Lippert; Pascaline Talmant; Marina Lafage-Pochitaloff; Dominique Leroux; Carine Gervais; Franck Viguié; Jean-Luc Lai; Christine Terre; Berna Beverlo; Costantina Sambani; Anne Hagemeijer; Peter Marynen; Georges Delsol; Nicole Dastugue; Cristina Mecucci; Pierre Brousset
Journal:  J Exp Med       Date:  2008-10-20       Impact factor: 14.307

View more
  26 in total

Review 1.  RNA-biology ruling cancer progression? Focus on 3'UTRs and splicing.

Authors:  Ayse Elif Erson-Bensan
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

2.  p53 regulates its own expression by an intrinsic exoribonuclease activity through AU-rich elements.

Authors:  Sanaz Derech-Haim; Yael Friedman; Amnon Hizi; Mary Bakhanashvili
Journal:  J Mol Med (Berl)       Date:  2020-02-04       Impact factor: 4.599

Review 3.  The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack.

Authors:  Abhishek Guha; Saboora Waris; Louis B Nabors; Natalia Filippova; Myriam Gorospe; Thaddaeus Kwan; Peter H King
Journal:  Adv Drug Deliv Rev       Date:  2021-12-16       Impact factor: 15.470

4.  The induced RNA-binding protein, HuR, targets 3'-UTR region of IL-6 mRNA and enhances its stabilization in periodontitis.

Authors:  K Ouhara; S Munenaga; M Kajiya; K Takeda; S Matsuda; Y Sato; Y Hamamoto; T Iwata; S Yamasaki; K Akutagawa; N Mizuno; T Fujita; E Sugiyama; H Kurihara
Journal:  Clin Exp Immunol       Date:  2018-03-08       Impact factor: 4.330

Review 5.  Connections between 3' end processing and DNA damage response: Ten years later.

Authors:  Michael Robert Murphy; Frida Esther Kleiman
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-10-28       Impact factor: 9.957

6.  CSDE1 attenuates microRNA-mediated silencing of PMEPA1 in melanoma.

Authors:  Pavan Kumar Kakumani; Tanit Guitart; Francois Houle; Louis-Mathieu Harvey; Benjamin Goyer; Lucie Germain; Fátima Gebauer; Martin J Simard
Journal:  Oncogene       Date:  2021-04-08       Impact factor: 9.867

7.  Interaction of RNA-binding protein HuR and miR-466i regulates GM-CSF expression.

Authors:  Jing Chen; William Adamiak; Ganlei Huang; Ulus Atasoy; Abdolmohamad Rostami; Shiguang Yu
Journal:  Sci Rep       Date:  2017-12-08       Impact factor: 4.379

Review 8.  Regulation of microRNA function in animals.

Authors:  Luca F R Gebert; Ian J MacRae
Journal:  Nat Rev Mol Cell Biol       Date:  2019-01       Impact factor: 94.444

Review 9.  Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancer.

Authors:  Sarah Blagden; Mai Abdel Mouti; James Chettle
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-08-01       Impact factor: 9.957

10.  MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.

Authors:  Zhen Zheng; Jia-Quan Qu; Hong-Mei Yi; Xu Ye; Wei Huang; Ta Xiao; Jiao-Yang Li; Yuan-Yuan Wang; Juan Feng; Jin-Feng Zhu; Shan-Shan Lu; Hong Yi; Zhi-Qiang Xiao
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.